NORTHWEST BIOTHERAPEUTICS INC
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
4800 MONTGOMERY LANE, BETHESDA, MD, 20814
Mailing Address
4800 MONTGOMERY LANE, BETHESDA, MD, 20814
Phone
(240) 497-9024
Fiscal Year End
1231
EIN
943306718
Financial Overview
FY2024
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 7, 2026 | View on SEC |
| 8-K Current report of material events | January 15, 2026 | View on SEC |
| 8-K Current report of material events | January 2, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | November 28, 2025 | View on SEC |
| 424B5 Prospectus supplement | November 25, 2025 | View on SEC |
| 8-K Current report of material events | November 20, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 31, 2025 | View on SEC |
| 8-K Current report of material events | October 30, 2025 | View on SEC |
| S-3 Shelf registration for future offerings | October 24, 2025 | View on SEC |
Material Events
8-K
Acquisition
April 7, 2026
High Impact
- Full vertical integration of DCVax-L manufacturing capabilities
- Elimination of third-party manufacturing fees and supply chain dependencies
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.